Higher Calcineurin Inhibitor Levels Associate with Graft Outcomes in Kidney Recipients with De Novo Donor-specific Antibodies of Either Hla Class I or II

被引：0
|
作者：
Beland, M. [1 ]
De Serres, S. [1 ]
机构：
[1] Univ Laval, CHU Quebec, Nephrol, Quebec City, PQ, Canada
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2021年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
1043
引用
收藏
页码：735 / 735
页数：1
相关论文
共 50 条
  • [1] HLA class, calcineurin inhibitor levels, and the risk of graft failure in kidney recipients with de novo donor-specific antibodies
    Beland, Marc-Antoine
    Lapointe, Isabelle
    Cote, Isabelle
    Lesage, Julie
    Houde, Isabelle
    Wagner, Eric
    Riopel, Julie
    Latulippe, Eva
    Desy, Olivier
    De Serres, Sacha A.
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [2] Higher calcineurin inhibitor levels predict better kidney graft survival in patients with de novo donor-specific anti-HLA antibodies: a cohort study
    Beland, Marc-Antoine
    Lapointe, Isabelle
    Noel, Real
    Cote, Isabelle
    Wagner, Eric
    Riopel, Julie
    Latulippe, Eva
    Desy, Olivier
    Beland, Stephanie
    Magee, Ciara N.
    Houde, Isabelle
    De Serres, Sacha A.
    TRANSPLANT INTERNATIONAL, 2017, 30 (05) : 502 - 509
  • [3] Graft Survival in De Novo Donor-Specific Antibodies and Positive Flow Crossmatch Kidney Transplants Is influenced by Class I and Class II
    Montag, S.
    Ho, B.
    Bhagat, H.
    Lee, E.
    Atiemo, K.
    Daud, A.
    Kang, R.
    Zhao, L.
    Schwartz, J.
    Ladner, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 224 - 224
  • [4] Predictors of graft failure after first detection of de novo donor-specific HLA antibodies in kidney transplant recipients
    del Moral, Covadonga Lopez
    Wu, Kaiyin
    Naik, Marcel
    Osmanodja, Bilgin
    Akifova, Aylin
    Lachmann, Nils
    Stauch, Diana
    Hergovits, Sabine
    Choi, Mira
    Bachmann, Friederike
    Halleck, Fabian
    Schrezenmeier, Eva
    Schmidt, Danilo
    Budde, Klemens
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 (01) : 84 - 94
  • [5] DE NOVO DONOR-SPECIFIC HLA ANTIBODIES IN LOW RISK PEDIATRIC KIDNEY TRANSPLANT RECIPIENTS
    Yilmaz, Alev
    Oguz, Fatma Savran
    Usta, Sebahat
    Yildirim, Zeynep Yuruk
    Pehlivanoglu, Cemile
    Kekik, Cigdem
    Emre, Sevinc
    PEDIATRIC NEPHROLOGY, 2015, 30 (09) : 1724 - 1724
  • [6] DE NOVO DONOR-SPECIFIC HLA ANTIBODIES IN LOW RISK PEDIATRIC KIDNEY TRANSPLANT RECIPIENTS
    Yilmaz, A.
    Yildirim, Z. Yuruk
    Pehlivanoglu, C.
    Nayir, A.
    Emre, S.
    Savran, F. Oguz
    Usta, S.
    Kekik, C.
    PEDIATRIC TRANSPLANTATION, 2015, 19 : 125 - 125
  • [7] Preformed Donor-specific Antibodies Against HLA Class II and Graft Outcomes in Deceased-donor Kidney Transplantation
    Uffing, Audrey
    Hidalgo, Luis G.
    McMullan, Giaran
    Perry, Jacqueline
    Milford, Edgar L.
    Murakami, Naoka
    Yeung, Melissa Y.
    Guleria, Indira
    Wood, Isabelle G.
    Akalin, Enver
    Azzi, Jamil
    Chandraker, Anil K.
    Riella, Leonardo, V
    TRANSPLANTATION DIRECT, 2019, 5 (05):
  • [8] De Novo Donor-Specific HLA Antibodies Decrease Patient and Graft Survival in Liver Transplant Recipients
    Kaneku, H.
    O'Leary, J. G.
    Banuelos, N.
    Jennings, L. W.
    Susskind, B. M.
    Klintmalm, G. B.
    Terasaki, P. I.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (06) : 1541 - 1548
  • [9] A Simple HLA Class II Matching Strategy for the Prediction of De Novo Donor-Specific HLA Antibodies
    Hidalgo, L. G.
    Juarez, I. A. Martinez
    Morales-Buenrostro, L.
    Shojai, S.
    Campbell, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 338 - 339
  • [10] Outcomes of Pancreas Transplant Recipients With De Novo Donor-specific Antibodies
    Parajuli, Sandesh
    Alagusundaramoorthy, Sayee
    Aziz, Fahad
    Garg, Neetika
    Redfield, Robert R.
    Sollinger, Hans
    Kaufman, Dixon
    Djamali, Arjang
    Odorico, Jon
    Mandelbrot, Didier
    TRANSPLANTATION, 2019, 103 (02) : 435 - 440
12345